Results 201 to 210 of about 131,342 (265)
An observational, non-interventional, multicenter, multinational registry of patients with atypical hemolytic uremic syndrome: initial patient characteristics [PDF]
, 2013 Ardissino, Gianluigi +10 more
core
Syndrome of Inappropriate Antidiuretic Hormone Secretion and Thrombotic Microangiopathy as Paraneoplastic Syndromes Complicating BRCA2-Mutated Metastatic Prostate Cancer. [PDF]
CureusShapoo N +4 more
europepmc +1 more source
Diagnostic Challenges in Atypical Hemolytic Uremic Syndrome: A Case of Artificial Mitral Valve Dysfunction as a Possible Trigger for Severe Thrombotic Microangiopathy. [PDF]
Am J Case RepKot G +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2002
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombus formation.
Daniel, Halevy +3 more
+8 more sources
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombus formation.
Daniel, Halevy +3 more
+8 more sources
European Urology, 2022
Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA) radioligand therapy is an option that is increasingly being used for treatment of metastatic castration-resistant prostate cancer.
H. Schäfer +10 more
semanticscholar +1 more source
Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA) radioligand therapy is an option that is increasingly being used for treatment of metastatic castration-resistant prostate cancer.
H. Schäfer +10 more
semanticscholar +1 more source
Thrombotic microangiopathy in patients with malignant hypertension.
Nephrology, Dialysis and Transplantation, 2022BACKGROUND Thrombotic microangiopathy (TMA) is a complication of malignant hypertension (mHTN) attributed to the high levels of blood pressure (BP). However, no studies have investigated in patients with mHTN of different etiologies whether the presence ...
T. Cavero +20 more
semanticscholar +1 more source
Seminars in Arthritis and Rheumatism, 2014
To review the clinical features and pathophysiologic mechanisms of the thrombotic microangiopathies (TMAs) including acquired and congenital thrombotic thrombocytopenic purpura (TTP), Shiga toxin-induced and atypical (non-Shiga toxin-induced) hemolytic uremic syndrome (HUS), and the TMAs associated with pregnancy, drugs, and organ transplantation ...
M, Starck, C-M, Wendtner
openaire +4 more sources
To review the clinical features and pathophysiologic mechanisms of the thrombotic microangiopathies (TMAs) including acquired and congenital thrombotic thrombocytopenic purpura (TTP), Shiga toxin-induced and atypical (non-Shiga toxin-induced) hemolytic uremic syndrome (HUS), and the TMAs associated with pregnancy, drugs, and organ transplantation ...
M, Starck, C-M, Wendtner
openaire +4 more sources
Pediatric Blood & Cancer, 2022
Transplant‐associated thrombotic microangiopathy (TA‐TMA) is an endothelial injury complication of hematopoietic stem cell transplant (HSCT) leading to end‐organ damage and high morbidity and mortality.
C. Higham +9 more
semanticscholar +1 more source
Transplant‐associated thrombotic microangiopathy (TA‐TMA) is an endothelial injury complication of hematopoietic stem cell transplant (HSCT) leading to end‐organ damage and high morbidity and mortality.
C. Higham +9 more
semanticscholar +1 more source